-
EP2992098
European procedure
Extract from the Register of European Patents
EP About this file: EP2992098
| EP2992098 - COMPOSITIONS AND METHODS FOR MODULATING HBV AND TTR EXPRESSION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.02.2020 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 22.02.2019 | ||
| Former | Grant of patent is intended Status updated on 18.02.2019 | ||
| Former | Examination is in progress Status updated on 29.01.2019 | ||
| Former | Grant of patent is intended Status updated on 20.09.2018 | ||
| Former | Examination is in progress Status updated on 03.11.2017 | Most recent event Tooltip | 07.02.2020 | No opposition filed within time limit | published on 11.03.2020 [2020/11] | Applicant(s) | For all designated states Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 / US | [2016/10] | Inventor(s) | 01 /
PRAKASH, Thazha, P. 2855 Gazelle Court Carlsbad, CA 92010 / US | 02 /
SETH, Punit, P. 2855 Gazelle Court Carlsbad, CA 92010 / US | 03 /
SWAYZE, Eric, E. 2855 Gazelle Court Carlsbad, CA 92010 / US | [2016/10] | Representative(s) | Learoyd, Stephanie Anne GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2016/10] | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | Application number, filing date | 14791344.6 | 01.05.2014 | [2016/10] | WO2014US36463 | Priority number, date | US201361818442P | 01.05.2013 Original published format: US 201361818442 P | US201361823826P | 15.05.2013 Original published format: US 201361823826 P | US201361843887P | 08.07.2013 Original published format: US 201361843887 P | US201361871673P | 29.08.2013 Original published format: US 201361871673 P | US201361880790P | 20.09.2013 Original published format: US 201361880790 P | US201461976991P | 08.04.2014 Original published format: US 201461976991 P | US201461986867P | 30.04.2014 Original published format: US 201461986867 P | [2016/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2014179627 | Date: | 06.11.2014 | Language: | EN | [2014/45] | Type: | A2 Application without search report | No.: | EP2992098 | Date: | 09.03.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.11.2014 takes the place of the publication of the European patent application. | [2016/10] | Type: | B1 Patent specification | No.: | EP2992098 | Date: | 27.03.2019 | Language: | EN | [2019/13] | Search report(s) | International search report - published on: | US | 16.04.2015 | (Supplementary) European search report - dispatched on: | EP | 08.12.2016 | Classification | IPC: | C12N15/113, A61P31/20, A61K31/7088, A61K31/713 | [2017/02] | CPC: |
A61K47/549 (EP,IL,RU,US);
C12N15/113 (EP,EA,IL,KR,RU,US);
A61K31/7125 (IL,RU);
A61K31/7088 (IL,MA,RU,US);
A61K31/7105 (IL);
A61K31/713 (IL,MA,RU,US);
A61K47/59 (EP,IL);
A61K48/00 (IL);
A61P25/00 (EP,IL);
A61P43/00 (EP,IL);
C07H21/00 (IL,RU);
C07H21/04 (IL,RU,US);
C12N15/111 (IL,RU,US);
C12N15/1137 (IL);
C12Y301/03048 (EP,IL);
C12N2310/11 (EP,IL,KR,US);
C12N2310/113 (IL,US);
C12N2310/14 (KR);
C12N2310/17 (IL,US);
C12N2310/31 (IL,US);
C12N2310/315 (EP,IL,KR,US);
C12N2310/32 (IL);
C12N2310/321 (IL,US);
C12N2310/322 (IL,US);
C12N2310/3231 (EP,IL,US);
C12N2310/3341 (EP,IL,US);
C12N2310/34 (IL);
C12N2310/341 (EP,IL,US);
C12N2310/346 (EP,IL,US);
C12N2310/35 (IL);
C12N2310/351 (EP,IL,KR,US);
C12N2310/3511 (IL,US);
C12N2310/3513 (IL,US);
C12N2310/3515 (IL,US);
C12N2310/3525 (IL,KR,US);
C12N2310/353 (IL,US);
C12N2320/32 (EP,IL,US)
(-)
| C-Set: |
C12N2310/321, C12N2310/3525 (US,EP);
C12N2310/322, C12N2310/3525 (US) |
| Former IPC [2016/10] | C12N15/113 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/10] | Extension states | BA | 27.11.2015 | ME | 27.11.2015 | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULIERUNG DER HBV- UND TTR-EXPRESSION | [2016/10] | English: | COMPOSITIONS AND METHODS FOR MODULATING HBV AND TTR EXPRESSION | [2016/10] | French: | COMPOSITIONS ET MÉTHODES POUR MODULER L'EXPRESSION DE HBV ET DE TTR | [2016/10] | Entry into regional phase | 27.11.2015 | National basic fee paid | 27.11.2015 | Search fee paid | 27.11.2015 | Designation fee(s) paid | 27.11.2015 | Examination fee paid | Examination procedure | 27.11.2015 | Examination requested [2016/10] | 13.07.2017 | Amendment by applicant (claims and/or description) | 02.11.2017 | Despatch of a communication from the examining division (Time limit: M06) | 11.05.2018 | Reply to a communication from the examining division | 21.09.2018 | Communication of intention to grant the patent | 29.01.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.01.2019 | Fee for grant paid | 29.01.2019 | Fee for publishing/printing paid | 18.02.2019 | Information about intention to grant a patent | 18.02.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19164959.9 / EP3524680 | EP19208621.3 Application refused : 05.07.2020 | EP20205948.1 / EP3828275 | EP25155370.7 | Opposition(s) | 03.01.2020 | No opposition filed within time limit [2020/11] | Fees paid | Renewal fee | 10.05.2016 | Renewal fee patent year 03 | 10.05.2017 | Renewal fee patent year 04 | 11.05.2018 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2009073809 (ALNYLAM PHARMACEUTICALS INC [US], et al); | [AD]WO2012037254 (ALNYLAM PHARMACEUTICALS INC [US], et al); | [A]US2013035366 (SWAYZE ERIC E [US], et al); | [A]WO2013033230 (ISIS PHARMACEUTICALS INC [US], et al) | International search | [Y]WO2009073809 (ALNYLAM PHARMACEUTICALS INC [US], et al); | [X]WO2011139917 (ISIS PHARMACEUTICALS INC [US], et al); | [A]US2012225927 (SAH DINAH WEN-YEE [US], et al); | [A]US2013035366 (SWAYZE ERIC E [US], et al); | by applicant | US12129154 | US60989574 | US61026995 | US61026998 | US61056564 | US61086231 | US61097787 | US61099844 | US3687808 | US4751219 | US4845205 | US5034506 | US5130302 | US5134066 | US5166315 | US5175273 | US5185444 | WO9414226 | US5367066 | US5432272 | US5457187 | US5459255 | US5484908 | US5502177 | US5525711 | US5552540 | US5587469 | US5594121 | US5596091 | US5614617 | WO9720563 | US5645985 | US5681941 | WO9746098 | US5698685 | WO9813381 | US5750692 | US5763588 | US5830653 | US5994517 | US6005096 | US6268490 | US6300319 | US6383812 | WO0243771 | US6525191 | US6525031 | US2003077829 | US2003119724 | US6620916 | US6660720 | US6670461 | WO2004024757 | US6770748 | US2004171570 | US6794499 | WO2004101619 | WO2004106356 | WO2005021570 | US6906182 | US2005130923 | US6908903 | US2005164235 | US7034133 | US7053207 | US2006148740 | US2006183886 | WO2007090071 | US7262177 | WO2007134181 | US2007287831 | US2008039618 | US2008108801 | US7399845 | WO2008101157 | WO2008098788 | US2008206869 | US7427672 | US2008281044 | US2008281041 | WO2008150729 | WO2008154401 | WO2009006478 | US7491805 | WO2009082607 | US7569686 | US2009203135 | US2009203132 | US7582744 | WO2009126933 | WO2009134487 | US2009286973 | WO2009143369 | WO2010036698 | WO2010054406 | US7723509 | WO2010077578 | WO2010088537 | US2010240730 | WO2010129709 | US7851615 | WO2010144740 | WO2010148013 | WO2011038356 | WO2011047312 | US2011097264 | US2011097265 | US2011123520 | WO2011100131 | US2011207799 | WO2011115818 | WO2011120053 | US2011269814 | WO2011163121 | US8106022 | US2012035115 | US8137695 | WO2012037254 | US8158601 | US2012095075 | US2012101148 | WO2012068187 | US2012128760 | US2012136042 | WO2012083185 | WO2012083046 | US2012157509 | US2012165393 | WO2012089352 | WO2012089602 | US2012230938 | WO2012145674 | WO2012145697 | US8313772 | WO2012177947 | US8344125 | US2013004427 | US8349308 | WO2013033230 | US8404862 | US2013109817 | US8435491 | US2013121954 | WO2013075035 | US8450467 | US2013178512 | US8501930 | US2013236968 | US8541548 | US8552163 | WO2013166121 | WO2013165816 | WO2008US64591 | WO2008US66154 | WO2008US68922 |